Company Performance Metrics
ViTi develops biotechnology solutions for infectious disease diagnostics, with an emphasis on blood-based assays for respiratory and immune-related pathogens. The company focuses on improving T cell diagnostics technology, particularly for pediatric tuberculosis, where conventional screening methods are often insufficient. ViTi designs and refines
immunological diagnostic assays that use specific cellular markers to identify infections more accurately. Its offerings include ViTi ONESENS, a proprietary assay for detecting defined T cell biomarkers, and ViTi ONESPEC, a specialized test aimed at tuberculosis screening and pathogen monitoring. These diagnostics are intended for use in clinical and research settings to support precision immunology and more reliable detection of active disease. ViTi positions its platforms to provide clinicians with actionable diagnostic data to inform patient care decisions.
